Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

No trades
See on Supercharts
Market capitalization
‪237.05 M‬USD
‪2.51 M‬USD
‪192.64 M‬USD
‪54.51 M‬
Beta (1Y)
0.40

About Vanda Pharmaceuticals Inc.

CEO
Mihael Hristos Polymeropoulos
Headquarters
Washington
Employees (FY)
203
Founded
2002
ISIN
US9216591084
FIGI
BBG000HT5MG6
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VNDA is 4.06 USD — it has decreased by 1.46% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vanda Pharmaceuticals Inc. stocks are traded under the ticker VNDA.
Vanda Pharmaceuticals Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Vanda Pharmaceuticals Inc. has a max estimate of 5.25 USD and a min estimate of 5.25 USD.
Vanda Pharmaceuticals Inc. revenue for the last quarter amounts to ‪38.82 M‬ USD despite the estimated figure of ‪44.50 M‬ USD. In the next quarter revenue is expected to reach ‪37.00 M‬ USD.
Yes, you can track Vanda Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, VNDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vanda Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
VNDA reached its all-time high on Dec 3, 2018 with the price of 33.44 USD, and its all-time low was 0.45 USD and was reached on Dec 23, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 203.00 employees. See our rating of the largest employees — is Vanda Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vanda Pharmaceuticals Inc. EBITDA is ‪−10.94 M‬ USD, and current EBITDA margin is −5.68%. See more stats in Vanda Pharmaceuticals Inc. financial statements.